Medication Adherence Therapy for Opioid Abusing Pain Patients
Status: | Completed |
---|---|
Conditions: | Chronic Pain |
Therapuetic Areas: | Musculoskeletal |
Healthy: | No |
Age Range: | 18 - Any |
Updated: | 1/11/2017 |
Start Date: | September 2000 |
End Date: | September 2005 |
The purpose of this study is to develop and pilot test a combined behavioral and
pharmacological intervention designed to decrease pain, functional interference, and drug
abuse while increasing medication adherence.
pharmacological intervention designed to decrease pain, functional interference, and drug
abuse while increasing medication adherence.
Project Pain is a Stage I behavioral therapies development project aimed at developing and
pilot testing a novel intervention for patients with chronic non-malignant pain who have
experienced difficulty managing prescribed opioids. The goals of the study are to: (1)
develop the intervention and training materials; (2) develop therapist adherence and
competence scales; (3) train therapists to deliver the intervention per the treatment
protocol; and (4) pilot the intervention to assess its feasibility, acceptability and
promise. The goals of the intervention are to: (1) improve adherence to prescribed opioids;
(2) decrease the severity of patients' pain; and (3) improve patients' functioning and
quality of life .
pilot testing a novel intervention for patients with chronic non-malignant pain who have
experienced difficulty managing prescribed opioids. The goals of the study are to: (1)
develop the intervention and training materials; (2) develop therapist adherence and
competence scales; (3) train therapists to deliver the intervention per the treatment
protocol; and (4) pilot the intervention to assess its feasibility, acceptability and
promise. The goals of the intervention are to: (1) improve adherence to prescribed opioids;
(2) decrease the severity of patients' pain; and (3) improve patients' functioning and
quality of life .
Inclusion Criteria:
- Uninterrupted pain of at least 6 months duration
- Pain is continuous, rather than intermittent
- Pain in the severe range (VAS = 7-10) while medicated
- Poor response to non-pharmacological interventions for pain (if appropriate)
- One or more of the following pain diagnoses: (a) back/neck pain; (b) myofacial pain;
(c) neuropathic pain (e.g., diabetic or AIDS neuropathy, Complex regional pain
syndrome); (d) arthritic pain; (e) MS; or (f) sickle cell (must meet chronicity
criteria)
- Evidence of tolerance/physiological dependence on opioid analgesics
- Current opioid use disorder (DSM-IV criteria)
- Continuous use of opioid analgesics for a minimum of 6 months prior to referral.
[Note: This is consistent with minimum 6-month requirement for diagnosis of chronic
pain].
- Minimum of 2 signs/symptoms of medication mismanagement identified by the Referring
MD (PROBLEMS WITH PAIN MEDS checklist)
Exclusion Criteria:
- Please contact site regarding exclusion criteria for this study.
We found this trial at
1
site
Click here to add this to my saved trials